Baird Medical and ExcelFin Acquisition Corp Complete Business Combination

Israel Acquisitions Corp. Announces Business Combination with Gadfin Ltd.

January 27, 2025

Aerospace & Defense

Israel Acquisitions Corp. (a Nasdaq-listed SPAC) and Israeli drone company Gadfin Ltd. entered into a definitive business combination agreement that values Gadfin's equity at up to $200 million. The transaction will take Gadfin public on Nasdaq, providing capital to scale its hydrogen-powered, long-range cargo drones and pursue global expansion across healthcare, logistics and defense end markets.

Baird Capital Invests in eCube Solutions

August 20, 2020

Aerospace & Defense

Baird Capital, the direct investment arm of Robert W. Baird & Co., has acquired an interest in eCube Solutions Limited, a UK-based provider of aircraft storage, disassembly and parts re-use and recycling services. The investment will fund expansion of eCube's UK operations, accelerate growth at its new continental European facility in Spain, expand parking and disassembly capacity, and support entry into the North American market.

Baird Capital Invests in Upfront Healthcare

November 17, 2020

Healthcare Services

Baird Capital has made a growth capital investment in Upfront Healthcare, a Chicago-based omnichannel patient engagement and communication platform founded in 2016. The investment is intended to support Upfront's continued growth and capability expansion to help health systems improve patient engagement and care delivery.

Boston Scientific Acquires Baylis Medical Company Inc.

October 6, 2021

Medical Devices

Boston Scientific Corporation agreed to acquire Baylis Medical Company Inc. for an upfront payment of $1.75 billion, subject to closing adjustments. The acquisition expands Boston Scientific’s electrophysiology and structural heart portfolios by adding Baylis’s RF NRG and VersaCross transseptal platforms and complementary guidewires, sheaths and dilators; Baylis was expected to generate nearly $200 million in net sales in 2022.

ENDYMED Merges with Majority Shareholder Shanghai Haohai Biological Technology

March 6, 2025

Medical Devices

ENDYMED Ltd completed a full merger with its majority shareholder and China distributor, Shanghai Haohai Biological Technology Co., Ltd, consolidating ownership and operations. The deal is intended to strengthen ENDYMED’s presence in China, streamline the global supply chain, accelerate innovation, and enhance the company’s global market competitiveness.

GHO Capital and Excellere Partners Invest in Biocare Medical

December 9, 2021

Medical Devices

London-based GHO Capital has invested in Biocare Medical, a California-headquartered developer of immunohistochemistry reagents and diagnostic instrumentation, alongside existing investor Excellere Partners. The capital will be used to accelerate R&D, expand the instrument offering, and support international expansion to capture growing demand for oncology diagnostics.